| Small & Micro Cap project
Caligan argues that Amag Pharmaceuticals has a collection of valuable assets
Caligan Partners, LP was founded by David Johnson and Sam Merksamer in 2017.
Even though Caligan Partners has filed a 13D in two stocks, Merksamer is no stranger to activism. He served as a managing director of Icahn Capital for eight years before launching Caligan Partners.
In October 2019, Amag Pharmaceuticals entered into a settlement agreement with Caligan after the investment firm launched a consent solicitation process to remove four board candidates. Caligan Partners argued that the individual components of the company’s portfolio are worth more than $30 per share, and the company enjoys several competitive advantages.
65, Sakhi Garden, 2nd Cross Street,
Okkiam Thoraipakkam, OMR, Chennai, India
Copyright by Snowball Research / March Intelligence Research LLP. All rights reserved.